Via360 Expands Canal-Based MIGS Options - Takeaways - MDSpire

Via360 Expands Canal-Based MIGS Options

  • By

  • Jim Gallagher, senior managing editor

  • May 1, 2026

  • 7 min

Share

  • 1

    The Via360 surgical system combines canaloplasty and trabeculotomy, offering enhanced control over viscoelastic delivery during glaucoma surgery.

  • 2

    The system received FDA 510(k) clearance in February 2025 for controlled viscoelastic delivery and trabecular meshwork incisions.

  • 3

    ActiveInject technology allows surgeons to deliver viscoelastic on demand, independent of catheter movement, enhancing procedural efficiency.

  • 4

    The device's microcatheter can advance 360° within Schlemm's canal, facilitating targeted treatment of outflow resistance.

  • 5

    Clinical experience indicates the Via360 system effectively reduces intraocular pressure and medication burden in patients with various glaucoma types.

Original Source(s)

Related Content